Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DYN Dyne Therapeutics	$10.32 -4.3%	$11.60	$6.36 ▼ $47.45	$1.17B	1.17	1.75 million shs	4.04 million shs
HLVX HilleVax	$1.86 -1.1%	$1.88	$1.34 ▼ $15.25	$93.26M	0.74	450,484 shs	179,854 shs
MODV ModivCare	$3.24 -10.5%	$1.77	$0.87 ▼ $32.82	$46.49M	0.76	1.48 million shs	1.15 million shs
OFIX Orthofix Medical	$10.34 -0.1%	$12.08	$10.25 ▼ $20.73	$405.12M	0.8	281,301 shs	814,462 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DYN Dyne Therapeutics	0.00%	-28.38%	-11.72%	-16.71%	-70.53%
HLVX HilleVax	0.00%	+0.54%	0.00%	+10.71%	-85.77%
MODV ModivCare	0.00%	+10.96%	+260.76%	+67.01%	-87.48%
OFIX Orthofix Medical	0.00%	-6.00%	-6.85%	-38.23%	-18.45%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DYN Dyne Therapeutics	2.5965 of 5 stars	4.5	0.0	0.0	1.7	3.3	0.0
HLVX HilleVax	2.3879 of 5 stars	3.0	3.0	0.0	0.0	3.3	1.3
MODV ModivCare	3.4502 of 5 stars	3.1	2.0	4.5	1.1	0.8	0.6
OFIX Orthofix Medical	2.8375 of 5 stars	3.4	2.0	0.0	1.5	3.3	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DYN Dyne Therapeutics	3.00	Buy	$43.93	325.66% Upside
HLVX HilleVax	2.00	Hold	$3.00	61.29% Upside
MODV ModivCare	2.25	Hold	$8.38	158.49% Upside
OFIX Orthofix Medical	2.75	Moderate Buy	$23.33	125.66% Upside

Current Analyst Ratings Breakdown

Latest MODV, OFIX, HLVX, and DYN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/18/2025	DYN Dyne Therapeutics	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$50.00
6/18/2025	DYN Dyne Therapeutics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$46.00 ➝ $32.00
6/17/2025	DYN Dyne Therapeutics	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$50.00
6/11/2025	DYN Dyne Therapeutics	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$37.00
6/6/2025	OFIX Orthofix Medical	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
6/2/2025	DYN Dyne Therapeutics	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$60.00 ➝ $34.00
5/29/2025	DYN Dyne Therapeutics	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$46.00
5/12/2025	MODV ModivCare	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform
5/9/2025	DYN Dyne Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$46.00 ➝ $38.00
5/9/2025	DYN Dyne Therapeutics	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$50.00 ➝ $50.00
3/31/2025	HLVX HilleVax	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$2.00 ➝ $2.00

(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DYN Dyne Therapeutics	N/A	N/A	N/A	N/A	$6.19 per share	N/A
HLVX HilleVax	N/A	N/A	N/A	N/A	$3.10 per share	N/A
MODV ModivCare	$2.79B	0.02	$16.20 per share	0.20	($2.69) per share	-1.20
OFIX Orthofix Medical	$799.49M	0.51	N/A	N/A	$13.07 per share	0.79

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DYN Dyne Therapeutics	-$317.42M	-$3.59	N/A	N/A	N/A	N/A	-52.83%	-48.84%	8/11/2025 (Estimated)
HLVX HilleVax	-$147.27M	-$2.15	N/A	N/A	N/A	N/A	-51.86%	-41.45%	8/14/2025 (Estimated)
MODV ModivCare	-$201.28M	-$16.10	N/A	20.25	N/A	-8.33%	13.64%	-1.19%	8/6/2025 (Estimated)
OFIX Orthofix Medical	-$126M	-$3.69	N/A	N/A	N/A	-17.78%	-28.15%	-16.51%	8/5/2025 (Estimated)

Latest MODV, OFIX, HLVX, and DYN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	DYN Dyne Therapeutics	-$0.88	-$1.05	-$0.17	-$1.05	N/A	N/A
5/8/2025	Q1 2025	HLVX HilleVax	-$0.37	-$0.12	+$0.25	-$0.12	N/A	N/A
3/28/2025	Q4 2024	HLVX HilleVax	-$0.33	-$0.35	-$0.02	-$0.68	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DYN Dyne Therapeutics	N/A	N/A	N/A	N/A	N/A
HLVX HilleVax	N/A	N/A	N/A	N/A	N/A
MODV ModivCare	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DYN Dyne Therapeutics	N/A	20.35	20.35
HLVX HilleVax	N/A	25.32	25.32
MODV ModivCare	N/A	0.80	0.80
OFIX Orthofix Medical	0.38	2.71	1.50

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DYN Dyne Therapeutics	96.68%
HLVX HilleVax	86.42%
MODV ModivCare	N/A
OFIX Orthofix Medical	89.76%

Insider Ownership

Company	Insider Ownership
DYN Dyne Therapeutics	20.77%
HLVX HilleVax	24.90%
MODV ModivCare	15.50%
OFIX Orthofix Medical	1.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DYN Dyne Therapeutics	100	113.67 million	90.06 million	Optionable
HLVX HilleVax	20	50.14 million	37.66 million	Not Optionable
MODV ModivCare	23,675	14.35 million	12.13 million	Optionable
OFIX Orthofix Medical	1,616	39.18 million	38.67 million	Optionable

MODV, OFIX, HLVX, and DYN Headlines

Recent News About These Companies

Orthofix Shareholders Meeting and Board Elections

June 20 at 9:54 AM | tipranks.com

Assenagon Asset Management S.A. Has $1.18 Million Stock Position in Orthofix Medical Inc. (NASDAQ:OFIX)

June 18, 2025 | marketbeat.com

Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System

June 17, 2025 | finance.yahoo.com

Orthofix Medical (NASDAQ:OFIX) shareholders have endured a 67% loss from investing in the stock five years ago

June 17, 2025 | finance.yahoo.com

Orthofix Medical Inc. (NASDAQ:OFIX) Short Interest Up 43.4% in May

June 16, 2025 | marketbeat.com

Orthofix Medical (NASDAQ:OFIX) Upgraded by Wall Street Zen to "Hold" Rating

June 15, 2025 | americanbankingnews.com

Wall Street Zen Upgrades Orthofix Medical (NASDAQ:OFIX) to "Hold"

June 14, 2025 | marketbeat.com

Wall Street Zen Downgrades Orthofix Medical (NASDAQ:OFIX) to Sell

June 7, 2025 | marketbeat.com

Orthofix Medical's (OFIX) Market Perform Rating Reaffirmed at JMP Securities

June 6, 2025 | marketbeat.com

Orthofix Medical Inc. (NASDAQ:OFIX) Director Purchases $24,570.00 in Stock

June 6, 2025 | insidertrades.com

Orthofix Medical Inc. (NASDAQ:OFIX) Short Interest Update

June 6, 2025 | marketbeat.com

Orthofix Reports Larger Than Expected Loss Per Share

June 5, 2025 | ryortho.com

Orthofix Medical Inc. (NASDAQ:OFIX) Director Alan Lee Bazaar Purchases 2,250 Shares

June 5, 2025 | marketbeat.com

Highridge Medical sells EBI bone healing division to focus on spine

June 5, 2025 | massdevice.com

Avista Healthcare Partners acquires Highridge Medical’s bone healing unit EBI

June 5, 2025 | pehub.com

Nuveen Asset Management LLC Cuts Holdings in Orthofix Medical Inc. (NASDAQ:OFIX)

June 4, 2025 | marketbeat.com

Millennium Management LLC Sells 33,052 Shares of Orthofix Medical Inc. (NASDAQ:OFIX)

June 1, 2025 | marketbeat.com

Orthofix in the headlines: 5 updates

May 23, 2025 | beckersspine.com

Orthofix Medical Inc. (NASDAQ:OFIX) Shares Sold by AWM Investment Company Inc.

May 23, 2025 | marketbeat.com

Massimo Calafiore Buys 10,000 Shares of Orthofix Medical Inc. (NASDAQ:OFIX) Stock

May 13, 2025 | insidertrades.com

Anderson Hospital Surgical Services Achieves Milestone With First 7D FLASH™ Navigation System Procedure

May 12, 2025 | riverbender.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MODV, OFIX, HLVX, and DYN Company Descriptions

Dyne Therapeutics NASDAQ:DYN

$10.32 -0.46 (-4.27%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$10.52 +0.21 (+1.99%)

As of 06/20/2025 06:37 PM Eastern

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

HilleVax NASDAQ:HLVX

$1.86 -0.02 (-1.06%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$1.88 +0.01 (+0.81%)

As of 06/20/2025 04:12 PM Eastern

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

ModivCare NASDAQ:MODV

$3.24 -0.38 (-10.50%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$3.17 -0.07 (-2.16%)

As of 06/20/2025 07:47 PM Eastern

ModivCare Inc., a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other. The company offers risk underwriting, contact center management, network credentialing, claims management, and non-emergency medical transport management services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. It also provides in-home personal care services, such as bathing, personal hygiene, grooming, oral care, dressing, medication reminders, meal planning, preparation and feeding, housekeeping, transportation services, prescription reminders, and assistance with dressing and ambulation services through placing non-medical personal care assistants, home health aides, and skilled nurses primarily to Medicaid patients in need of care monitoring and assistance in performing daily living activities, including senior citizens and disabled adults. In addition, the company offers remote patient monitoring solutions, including personal emergency response systems, vitals monitoring, medication management, and data-driven patient engagement solutions. It serves federal, state, and local government agencies, MCOs, commercial insurers, private individuals, and health systems. The company was formerly known as The Providence Service Corporation and changed its name to ModivCare Inc. in January 2021. ModivCare Inc. was incorporated in 1996 and is headquartered in Denver, Colorado.

Orthofix Medical NASDAQ:OFIX

$10.34 -0.01 (-0.10%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$10.34 0.00 (-0.05%)

As of 06/20/2025 04:14 PM Eastern

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time